Hepalink Pharma IPO: Trading Debut
Shenzhen HepaLink Pharmaceuticals (H) (HEPALINK HK) is a leading China-based pharmaceutical company with global businesses in pharmaceutical,...
409 Views
Shenzhen Hepalink (海普瑞) A+H Trading: 20% Upside Thanks to A-Share Performance
Shenzhen Hepalink raised HKD 3,806 million (USD 491 m) from its global offering and will list on the Hong Kong Stock Exchange tomorrow. In our...
430 Views
ECM Weekly (27 June 2020) - Smoore, Ocumension, Hepalink, Immunotech, Sri Trang Gloves, Yum China HK
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. It...
365 Views
Hepalink Pharma IPO: Valuation Insights
Shenzhen HepaLink Pharmaceuticals (H) (HEPALINK HK) is a leading China-based pharmaceutical company with global businesses in pharmaceutical,...
481 Views
Shenzhen Hepalink (海瑞普) A+H: Hot Deal that Might Not Fly
Shenzhen Hepalink, a leading heparin manufacturer in China, launched book building to raise up to USD 585 million to list in Hong Kong. In our...
490 Views